Work

Abstract 402: BCL6 degrader with novel CRBN ligand demonstrates promising selectivity and preclinical efficacy alone or in combination with BCL2 inhibitor

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-402

Authors: Jun Xu, Yangguang Li, Ju Wang, Pingmin Tang, Yuting Liao, Chen Zhang, Pangke Yan

Institution: Haisco Pharmaceutical Group Co., Ltd. (China)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409690414

Cites:

Cited by:

Related to: 10